2022
DOI: 10.1016/j.brainres.2021.147750
|View full text |Cite
|
Sign up to set email alerts
|

The neuroprotective properties and therapeutic potential of epidermal neural crest stem cells transplantation in a rat model of vascular dementia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
16
1

Year Published

2022
2022
2023
2023

Publication Types

Select...
6
1

Relationship

4
3

Authors

Journals

citations
Cited by 10 publications
(19 citation statements)
references
References 63 publications
2
16
1
Order By: Relevance
“…We performed the allograft transplantation of 1 million ESC without immunosuppression was repeated three times after 2VO surgery. In our previous study, the transplantation of 1 million cells showed better functional recovery in the 2VO rats to 2.5 million cell grafting 11 .…”
Section: Discussionmentioning
confidence: 75%
See 3 more Smart Citations
“…We performed the allograft transplantation of 1 million ESC without immunosuppression was repeated three times after 2VO surgery. In our previous study, the transplantation of 1 million cells showed better functional recovery in the 2VO rats to 2.5 million cell grafting 11 .…”
Section: Discussionmentioning
confidence: 75%
“…Perhaps the synergistic effect of combination therapy in releasing the growth factors on the host neural circuits caused this functional improvement without any new circuits between the host and grafted cells. Previous reports have suggested the hippocampal synaptic plasticity improvement following stem cell transplantation in 2VO and myocardial infarction models 11,31 . It has been indicated that EPI-NCSCs could express the vascular endothelial growth factor (VEGF), Neurotrophic growth factor (NGF), and Brain-derived neurotrophic factor (BDNF), [32][33][34] .…”
Section: Discussionmentioning
confidence: 90%
See 2 more Smart Citations
“…Isolation of hair follicles from the skin does not raise ethical concerns and by autologous transplantation, immunological graft rejection would be avoided. In addition, up to now, no immunological rejection are reported following allograft or xenograft transplantation of HFSCs in several nervous system conditions such as Alzheimer’s disease [ 10 ], vascular dementia [ 11 ], peripheral nerve injury [ 12 ], also animals [ 13 ] and organotypic [ 14 , 15 ] models of spinal cord injury. Moreover, HFSCs express a wide range of extracellular proteases, angiogenic factors, and growth factors that eventually may lead to neuroprotection and neo-vascularization [ 16 ].…”
Section: Introductionmentioning
confidence: 99%